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In recent studies, it has been observed that genes that have been duplicated during the 
course of vertebrate evolution are overrepresented among those genes that cause Mendelian 
diseases. My objective was to determine whether measures of functional divergence are 
correlated with the propensity of duplicated genes to be involved in Mendelian disease. To test 
this, I used a phylogeny-based maximum-likelihood mixture-model prediction program, FunDi, 
that accounts for functional divergence in phylogenetic trees. I then conducted a statistical 
analysis of the data, measuring the Rho value of functional divergence weight and branch lengths 
values, using a Pearson correlation test and two-sided Wilcoxon-Mann-Whitney U-test. 
Statistically significant correlation was found for the relationship between the length of the 
branch in the phylogenetic tree separating disease-associated genes and its orthologs from the 
rest of the gene family and the propensity for a gene to be involved in autosomal recessive 
disorders. Optimization with FunDi, which accounts for functional divergence in its model, 
resulted in shorter branch lengths. Unfortunately, no statistical significance was found between 
the analyzed gene categories for the Rho value. Therefore, I conclude that while some measures 
of evolution and functional divergence, such as the internal branch length between groups, may 
be correlated with disease-association, direct measures of functional divergence measured in this 
study do not explain the propensity of duplicated genes to be involved in Mendelian diseases. 
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List of Abbreviations and Symbols Used 
 
 
Δ  Delta 
AD   Autosomal Dominant  
AR   Autosomal Recessive 
CFTR   Cystic Fibrosis Transmembrane Conductance Regulator  
DMD   Dystrophin Gene 
DNA   Deoxyribonucleic Acid 
EMF   Enhanced MetaFile 
ETE   Environment for Tree Exploration 
FASTA  FAST-All 
FD  Functional divergence/functionally divergent 
FMRP  Fragile X Mental Retardation Protein 
FMR1   Fragile X Mental Retardation 1 Gene 
FunDi   Phylogeny-based Functional Divergence Prediction Program 
HTT   Huntingtin Gene 
IQ-Tree  Efficient Phylogenomic Software by Maximum Likelihood 
JTT  Jones-Taylor-Thornton 
LG   Le and Gascuel 
MD   Monogenic / Mendelian Disease 
ND   Non-Disease 
Rho   Functional Divergence Weight Parameter 








Deoxyribonucleic acid (DNA) is a polymer of nucleic acids that carries the genetic instructions 
for the growth, function, development, and reproduction of all living organisms. Damage to 
DNA can cause genetic alterations, known as mutations, which can lead to hereditary diseases. It 
is important to note that mutations are not always harmful. In most cases, they are neutral, and in 
some instances, can even be beneficial (Ohta, 1973; Ohta & Gillespie, 1996). Human hereditary 
diseases are broadly classified as either monogenic or complex disease, based on whether they 
are caused by mutations in a single gene, or multiple genes. Monogenic diseases (also known as 
Mendelian diseases) are caused by mutations that lead to changes in the function of a single 
gene, including the complete loss of function. Sickle cell anemia, Marfan syndrome, 
Huntington’s disease, and cystic fibrosis are all examples of monogenic diseases (Carter, 1977; 
Rees et al., 2010; Dietz & Cutting, 1991; Roos, 2010; Zielenski et al., 1991). Some Mendelian 
diseases are more common in certain areas and populations. For example, Fabry’s disease and 
Niemann-Pick disease are particularly common in Nova Scotia (Greer et al., 1998; Kirkilionos et 
al., 1991). The Finnish Heritage diseases, which are a collection of approximately 40 rare genetic 
diseases (Norio, 2003), are common among ethnic Finns. In addition, many monogenic diseases 
are more commonly found in Ashkenazi Jewish populations, such as Canavan disease, Gaucher 
disease, familial dysautonomia, Bloom syndrome, and Fanconi anemia (Scott et al., 2010). 
Complex genetic diseases (also known as polygenic diseases) are responsible for the vast 
majority of human genetic-related diseases, and are caused by mutations in multiple genes that 
must be inherited together (Wink, 2006), and may also be influenced by the environment (Caspi 
et al., 2010). Many different mutations, with smaller effects, all contribute to the risk for a 
polygenic disease. Examples of polygenic diseases include coronary heart disease, many cancers, 
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Type 2 diabetes, and a number of birth defects and psychiatric disorders (Weeks & Lathrop, 
1995; Taylor, 1999; Swerdlow et al., 2012). Related to complex diseases are those that are 
caused by acquired genetic mutations, called acquired genetic disorders (Risch & Merikangas, 
1996). These develop during one’s lifetime and include cancer and “cancer-like” diseases such as 
myelodysplastic syndrome and thrombocytopenia (Mijović & Mufti 1998; Drachman, 2004).  
Deleterious mutations can be either “loss-of-function” or “gain-of-function”. Loss-of-
function (inactivating/null) mutations result in a gene product that has reduced or no function, 
while gain-of-function (activating) mutations result in a gene product that has a new or enhanced 
function, pattern of gene expression, or regulation. Some genes can be essential to the viability of 
organisms because they can acquire deleterious mutations that cause loss-of-function or null 
mutations in genes. These mutations do not affect the phenotype and in turn, the organism's 
viability. Other gene families have been described as “dangerous”, due to their tendency to 
acquire deleterious gain-of-function mutations, which increases their susceptibility to genetic 
diseases (Singh et al., 2012; Singh et al., 2014). In both cases, functional divergence can play an 
important role in gene evolution and functionality in the organism, and is a driving force in the 
evolution of genes involved in genetic diseases, including Mendelian disease.  
 
1.1 Mendelian Diseases 
Mendelian disease genes follow four main patterns of inheritance: autosomal dominant, 
autosomal recessive, X-linked recessive, and X-linked dominant (Chial, 2008). In the autosomal 
dominant pattern, a disease occurs when one copy of an allele is mutated and the disease will 
typically appear in every generation of the family. An example of this type of Mendelian 
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inheritance is Huntington’s disease, which is a progressive disorder of motor, cognitive, and 
psychiatric changes. This disease is caused by a genetic defect that alters the Huntingtin (HTT) 
gene on chromosome 4 (Roos, 2010), which changes the number of C-A-G trinucleotide repeats 
in the gene (Ross & Tabrizi, 2011). Generally, the number of repeats is between 10 and 35, but 
Huntington’s disease occurs when these increase to 36 or more, which produces a longer and 
unstable Huntingtin protein (HTT) that ultimately leads to neurodegeneration (Finkbeiner, 2011). 
In autosomal recessive diseases, two copies of the harmful allele must be present for the 
individual to express the disease. The disease will not appear in every generation of the family, 
but carriers will be present in every generation. A typical example of a Mendelian disease with 
autosomal recessive inheritance is cystic fibrosis (Zielenski et al., 1991). This relatively common 
genetic disease occurs in about 1 in 3,500 individuals of European descent (Ratjen, 2009), and is 
caused by the loss-of-function of a chloride channel, which is coded for by the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene on chromosome 7 (Zielenski et al., 1991). 
The loss-of-function mutations in the protein leads to an accumulation of thick mucus in the 
digestive, reproductive, and respiratory systems, leading to an increase in inflammation, 
infection, and respiratory problems (Zielenski et al., 1991; Welsh & Smith, 1993). 
X-linked diseases operate the same way as diseases on autosomes, except that males only 
have one copy of the X chromosome. This means that if a mutation appears on the X 
chromosome, the male will be affected. Since females have two copies of the X chromosome, X-
linked recessive diseases are more common among men. An example of a disease with an X-
linked recessive pattern of inheritance is Duchenne muscular dystrophy. The disease is caused by 
a mutation of the dystrophin gene (DMD) located at the short arm of the X chromosome (Blake 
& Kröger, 2000). Mutation of the DMD gene prevents the creation of the protein dystrophin, 
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which leads to an excess of calcium in the cell membrane, alters cell signaling pathways, and 
ultimately leads to a progressive muscular disorder (Dobyns et al., 2004). Fragile X syndrome is 
a disease with an X-linked dominant pattern of inheritance, which is caused by mutation in the 
fragile X mental retardation 1 (FMR1) gene, located on the X chromosome. Similar to 
Huntington's disease, the mutation alters the length of the gene by expending the C-G-G 
trinucleotide repeats in the gene. The number of repeats is increased from between 5 and 44 to 45 
or more, resulting in failure to express a normal protein (FMRP) which leads to abnormal neural 
development (Hagerman, 2005; Garber et al., 2008).  
 
1.2 Mendelian Diseases and Gene Duplications 
It has been observed that genes that have been duplicated are overrepresented among genes that 
cause Mendelian diseases (Chen et al., 2013; Chen et al., 2014; Singh et al., 2012; Singh et al., 
2014). Duplicated genes result from gene or genome duplications, which are important 
mechanisms for creating genetic variation and novelty in organisms (Stephens, 1951; Magadum 
et al., 2013) by providing new genetic material for mutation, drift, and selection to act upon. 
Many new gene functions have evolved through the process of gene duplication (Alberts et al., 
2002; Wolfe & Li, 2003). These duplications are divided into two main categories: small-scale 
duplication and whole-genome duplication (Dehal & Boore, 2005). Small-scale duplication 
occurs when a specific region of the genome, containing a single gene or a few genes located 
close together, is duplicated. Genes that originate from small-scale duplication are highly diverse 
in their function and are thought to be more essential (Hakes et al., 2007). Whole-genome 
duplications are large-scale events where the entire genome is duplicated, resulting in additional 
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copies of the genome (polyploidy) (Dehal & Boore, 2005). Polyploid cells contain more than two 
paired (homologous) chromosome sets. Genomes that have been duplicated in this fashion 
eventually return to a diploid state (diploidization), and some gene copies are lost or gained 
during this process (Conrad & Antonarakis, 2007). Because of this, genes that originate from 
whole-genome duplication are less diverse in their functions, are thought to be less essential, and 
are more likely to be members of a protein complex (Hakes et al., 2007). Since small-scale 
duplication provides no immediate benefit, they will have low probability to be retained and will 
be rapidly lost following the duplication. Whole-genome duplication, on the other hand, can 
provide immediate benefit thus selection will act stronger to retain these duplicates (Hakes et al., 
2007). During the course of vertebrate evolution, two rounds of whole-genome duplication have 
occurred, and this is hypothesized to be a driving force behind increases in organismal 
complexity (Brunet et al., 2006; Acharya & Ghosh, 2016). This hypothesis argues that gene 
duplication created genetic redundancy, which allowed for novel genes and gene functions to 
develop (Chen et al., 2013; Chen et al., 2014). This redundancy reduces or changes the 
functional constraints that otherwise operated on the original single gene (Qian & Zhang, 2014).  
Duplicated genes are called paralogs. These paralogs typically perform the same role as 
the original single gene initially, but can diverge over time (Innan & Kondrasov, 2010). After 
gene duplication, most duplicated genes acquire mutations that render them nonfunctional 
quickly (in evolutionary time) (Hughes, 1994; Hurles, 2004). These non-functional paralogs are 
called “pseudogenes”. Over time, many of these pseudogenes are completely lost from the 
genome, along with its functionality (Hughes, 1994; Hurles, 2004; Ohno, 1970; Hufton & 
Panopoulou, 2009). However, over the course of evolution, mutation and selection can act 
independently on the duplicate copies, leading to functional divergence between paralogs. The 
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main types of functional divergence are neofunctionalization, an adaptive process where one 
paralog acquires a new function that was not present in the pre-duplicated gene, and 
subfunctionalization, which can be either an adaptive or neutral process where both paralogs in a 
duplicated gene partition the ancestral function (Rastogi & Liberles, 2005; Innan & Kondrasov, 
2010). For example, the creation of hemoglobin, myoglobin, and cytoglobin from one ancestral 
gene (Hoffmann et al., 2011; Ebner et al., 2003), is an example of gene duplications followed by 
functional divergence. Currently, all three proteins perform a similar role in binding oxygen, but 
their specific function and tissue-specific expression differs. 
As stated previously, genes that cause Mendelian disease are enriched in duplicated genes 
(Dickerson & Robertson, 2011; Chen et al., 2013; Chen et al., 2014; Singh et al., 2012; Singh et 
al., 2014). This observation was unexpected, as it was previously hypothesized that singletons 
(genes without duplicates) were more likely to be functionally critical as paralogous genes could 
potentially compensate for one another and mask the effects of deleterious mutations (Brunet et 
al., 2006; Gu et al., 2003; Dickerson & Robertson, 2011; Chen et al., 2012; Chen et al., 2013; 
Chen et al., 2014). Several proposals have been put forward to explain this observation. First, the 
age of the duplicates may play a major role in their ability to functionally compensate for one 
another when there is a mutation in one of the paralogs. In the case of ancient duplications, due 
to the amount of time that has passed, functional divergence is more likely to have occurred. This 
functional divergence prevents the paralogous genes from functionally compensating for one 
another (Chen et al., 2013; Chen et al., 2014). In contrast to older duplication events, paralogs 
that result from more recent duplication events might still be able to functionally compensate for 
mutations in their gene duplicate. This means that if a mutation or damage occurs in one copy of 
the gene, the other copy will still produce a normal and functional gene product. In the absence 
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of strong functional divergence, both paralogs can perform the same functions and are typically 
still expressed in the same tissues. Second, whole-genome duplication created the potential for 
more complex systems, as all genes were duplicated at the same time, allowing more 
opportunities for functional divergence. Gene divergence would then expose the deleterious 
effect of genetic alterations (mutations) and lead to disease. Existing studies have shown that 
genes that are prone to dominant deleterious mutations are considered to be more "dangerous" 
(Singh et al., 2012; Singh et al., 2014). In addition, functional compensation by duplication of 
genes masks the phenotypic effects of deleterious mutations and reduces the probability of 
purging the defective genes from human population (Chen et al., 2013; Chen et al., 2014). 
Mendelian diseases can have a large burden on human health. This includes both loss of 
life and decreased quality of life, because most aren’t fatal (Costa et al., 1985; Botstein & Risch, 
2003). Though relatively rare individually, it is estimated that over 10,000 human diseases are 
known to be Mendelian, and the global prevalence is approximately 10/1000 individuals at birth 
(World Health Organization, 2016; Chakravarti, 2011). In this project, the focus is on genes that 
can lead to Mendelian diseases when mutated. Understanding the mechanism of genes and 
diseases has long been a point of interest in genetic research. There are still many Mendelian 
diseases where the causal mutation and gene are not yet known. Discovering and analyzing the 
genetic basis of known Mendelian diseases will contribute to our knowledge of gene function 
and regulation and will also allow us to develop better treatment methods in the future (Chong et 
al., 2015). Today genome-scale analyses are incredibly useful for identifying genetic mutations; 
however, the small number of rare mutations found in a typical genome means we need to 
develop methods that will prioritize genes likely to be involved in Mendelian disease. 
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1.3 Thesis Objectives 
In this project, I hypothesize that direct measures of functional divergence between paralogs are 
associated with the propensity of duplicated genes to be involved in Mendelian disease. I test my 
hypothesis by using a phylogeny-based, functional divergence prediction program, FunDi 
(Gaston et al., 2011), to analyze ~9000 gene families. These families include both genes 
involved in Mendelian disease and non-disease genes. I predict that when comparing gene 
families that contain genes that cause Mendelian disease to gene families that do not, measures 
of functional divergence produced by FunDi, particularly the functional divergence score, will be 
higher in the gene families that are involved in Mendelian diseases. This is due to the 
compensation hypothesis where genes become too diverse (=higher functional divergence) and 
cannot compensate each other, leading to Mendelian disease when a mutation is acquired. 
Additionally, I predict that when comparing the two main patterns of Mendelian inheritance in 
autosomal (non-sex chromosome) genes, autosomal dominant and autosomal recessive, the 
functional divergence score will be the highest for genes involved in autosomal dominant 
disorders. This is due to the strength of the pattern of inheritance, where in the dominant pattern 
a defect in one allele can lead to disease, which also based on the compensation hypothesis. I 
propose that having a tool that can analyze genes, and output a significant functional divergence 
score, will aid in identifying new disease-causing genes; helping us gain a better understanding 






2.1 Data Acquisition, Cleaning, and Integration 
To construct a dataset of human gene families, I downloaded 15,570 gene sequence alignments 
and phylogenetic trees from TreeFam (v9) (Schreiber et al., 2012). This approach was based on 
the method used by Chen et al. (2013); however, only alignments and phylogenetic trees of gene 
families (where at least two paralogous human sequences are present in the alignment and tree) 
were retained, for a total of 8,166 sequence alignments and their respective phylogenetic trees. 
Genes were then linked to extra information, particularly their disease categorization (non-
disease, recessive, dominant, etc.), from the Chen et al. (2013) supplementary data by using the 
TreeFam group identifier, Ensembl identifiers and a custom python script.  
In this analysis, I was specifically interested in the relationship between functional 
divergence and the disease-causing potential of duplicated genes. Additionally, because FunDi in 
this analysis uses the program IQ-TREE to perform the maximum-likelihood phylogenetic 
analyses, a minimum of three taxa in each defined subgroup of the phylogenetic tree is required 
(IQ-TREE, 2016) as this is how the program was built. Therefore, 250 of the multiple sequence 
alignment files that had fewer than three taxa in each defined subgroup of the phylogenetic tree 
were removed from the analysis. Due to polytomies (unresolved evolutionary relationships in 
which three or more branches originate from the same node, particularly at the root of the tree 
(Olmstead, 1996, Lin et al., 2011)) in some phylogenetic trees, an additional 1,500 multiple 
sequence alignment files were removed from my dataset. After filtering and cleaning the dataset 
of human gene families from the mentioned datasets, a total of 6,416 gene family alignments and 
phylogenetic trees were analyzed using FunDi. Because the phylogenetic tree information was 
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encoded in the EMF (Enhanced MetaFile) file format, and multiple sequence alignments in 
FASTA (text-based format for representing peptide sequences) files, custom python scripts were 
written to extract newick-format phylogenetic trees from EMF files and to convert FASTA-
format sequence alignments to the phylip-format used by FunDi. 
Having only the Ensembl gene ID’s of interest from Chen et al.’s (2013) dataset as a 
starting point, a datasheet that contained all human gene families, as our dataset and their 
associated paralog proteins, was created (Fig. 1). 
 
2.2 Subtree Definition File Creation  
The subtree definition files define two different subgroups within multi-member gene families. 
FunDi separates the tree into its constituent subtrees, using the subtree definition file as a map 
that identified which sequences will be in each of the two subgroups to be considered in the 
analysis. Knowing only the protein ID’s as our starting point, a connection to its’ paralogs was 
required. To split the tree files into subgroups, an algorithm was written in python that uses the 
ETE v3 (Environment for Tree Exploration v.3.0.0b35) package (Huerta-Cepas et al., 2016; ETE 
Toolkit - Analysis and Visualization of (phylogenetic) trees, 2016). This toolkit allows 
programmatic access to, and manipulation of, a phylogenetic tree. Specifically, the subtree 
definition files were generated using the following algorithm (Fig. 2): 
 
1. Iterate through the terminal (leaf) nodes of the tree until the node corresponding with 
the protein of interest is found. 
2. Starting from the terminal node containing the identified protein in 1, move to the 
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parental node. Check all terminal nodes that are a descendant of this node to see if they 
contain a human protein identifier, excluding the original protein of interest. If a human 
paralog is identified here, then stop and proceed to step 4. Otherwise continue with step 
3. 
3. Repeat step 2 by continuing to traverse through ancestral nodes, towards the root of the 
tree, until a terminal node with a descendant terminal node corresponding to a human 
protein other than the original protein of interest is found. 
4. Once an internal node of the tree that has a descendant node corresponding to a human 
protein other than the original protein of interest is identified, go to the previous internal 
node tested, as that was the last node that did not contain this paralog as a descendant. 
5. Create a list that contains the sequence identifiers of all terminal nodes descended from 
the internal node identified in 4.  
6. Iterate over all the terminal nodes in the tree and create a second list of all sequence 
identifiers that do not appear in the list created in 5. 
7. Create a subtree definition file whose first line is list of nodes from step 5 and a second 
line that has the list of nodes from step 6. 
 
2.3 FunDi Analysis 
FunDi is a phylogenetic maximum-likelihood mixture-model prediction program that identifies 
functionally divergent sites among protein families, using specified models of amino acid 
substitution (Gaston et al., 2011). A proper FunDi run of each gene family in the dataset uses the 
following files: a multiple sequence alignment file (phylip), a phylogenetic tree file (newick), 
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and a subtree definition file. FunDi compares two subgroups in each gene family: a subgroup 
defined by a human protein sequence of interest along with its orthologs and the rest of the 
sequences in the gene family. In the case where a gene family contains three or more human 
paralogs FunDi will conduct one comparison per paralog. 
FunDi uses a two-component mixture model where sites in the multiple sequence 
alignment are modelled using a dependent component (standard evolutionary model) and an 
independent model, where the specified subtrees of gene family’s phylogenetic tree are treated as 
completely independent trees. After maximum-likelihood optimization, a site-wise posterior 
probability of functional divergence for each site in the alignment is calculated, where the 
independent model approximates functional divergence. In the dependent component (non-
functionally divergent), the maximum-likelihood evaluation of the tree as a whole reflects 
normal evolutionary models, where all of the evolutionary parameters (i.e.: evolutionary rate, 
and amino acid frequency) are the same across the phylogenetic tree. The independent 
(functionally divergent) component models the two subtrees as independent of one another; 
therefore, the subtrees can be optimized to different evolutionary rates amino acid frequencies, 
and other evolutionary parameters between the two parts of the phylogenetic tree. FunDi 
optimizes the overall ratio between the independent and dependent components, the branch 
length between the two groups, and finally estimates a functional divergence value. The 
determination of whether the site is functionally divergent or not is dependent on a set cut-off 
threshold (standard threshold is 0.5). In our analysis, we set different thresholds (0.75, 0.9, and 
0.95) to test the weight of functional divergence of the different sites in the alignment files. The 
use of the two components is an attempt to statistically and computationally model the process of 
molecular evolution when functional divergence might be occurring.  
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 FunDi analysis used the LG model of amino acid substitution, a gamma distribution of 
evolutionary rates among sites in the sequence alignment, and an empirically estimated 
frequency of individual amino acids in the multiple sequence alignment. The LG model is one of 
many amino acid replacement matrices (such as WAG (Whelan & Goldman, 2001), JTT (Jones 
et al., 1992), and PAM (Dayhoff et al., 1978)) that are used in protein phylogenetic inference (Le 
& Gascuel, 2008). These models are used to calculate probabilities of amino acid substitution 
along branches of phylogenetic trees. The dataset of multiple sequence alignments that was used 
to construct the LG substitution matrix was larger and contained a more diverse set of sequences 
(Le & Gascuel, 2008). The gamma distribution is used to model multiple rates of evolution at 
sites in the multiple sequence alignment, allowing for faster or slower evolving sites (Yang, 
1994; Yang, 1996). The shape of this gamma distribution of site-rate categories is controlled by 
the shape parameter alpha, which is optimized during the maximum-likelihood optimization 
process.  
 FunDi uses the site log-likelihood values estimated by the program IQ-TREE (v.1.5.0) 
(Nguyen et al., 2015; IQ-TREE, 2016). IQ-TREE takes the provided phylogenetic tree and 
multiple sequence alignment and re-optimizes branch lengths, the gamma shape-parameter alpha, 
and other aspects of the phylogenetic tree, with the exception of the tree topology, given the 
provided evolutionary model as described previously. 
 Branch length optimization was used in FunDi for each phylogenetic tree, in order to 
properly model functional divergence. In some cases, this results in the shortening of the internal 
branch length, which can be artificially inflated under standard evolutionary models that do not 
account for functional divergence. This optimization allowed me to estimate the optimal 
maximum-likelihood tree, with optimized branch lengths. FunDi output the following values: 
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fraction of functionally divergent sites, optimal branch length of the internal branch separating 
the defined subgroups, and the optimized weight parameter, Rho, for the independent (functional 
divergence) model component. 
The branch lengths in some of the analyzed tree files were theoretically very long and 
before using FunDi program, are referred to as “un-optimized”. They are referenced in the 
following figures as the “Pre-FunDi Branch Length”. As mentioned, FunDi uses the IQ-TREE 
(v.1.5.0) algorithm (Nguyen et al., 2015; IQ-TREE, 2016) that takes the provided phylogenetic 
tree file and re-optimizes the branch lengths. After optimizing the phylogenetic trees with FunDi, 
the branch length we considered “optimized” and were described as “Post-FunDi Branch 
Length”.  
  
2.4 Statistical Analysis and Data Visualization 
A number of statistical tests and data visualization methods were used to examine the association 
between functional divergence and the disease-causing status of genes. 
 Comparisons of the functional divergence weight (Rho) were made between gene-
families that cause Mendelian-disease (MD) vs non-disease (ND) gene-families. In addition, we 
specifically compared autosomal dominant (AD) and autosomal recessive (AR) genes. 
While Rho is the most direct measure of functional divergence output by FunDi, 
additional comparisons were made between the fraction of functionally divergent sites for genes 
in the AD and AR disease categories (that represent the subcategories of MD) when compared to 
those in the ND category, using different cut-offs (0.5, 0.75, 0.9, and 0.95) for the site-wise 
posterior probability of functional divergence output by FunDi. 
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The various comparisons were plotted as box plots or scatter plots, and analyzed using 
Minitab v.17 (Minitab 17, 2016), with focus on internal branch length (branch length separating 
a subgroup of interest from the rest of a phylogenetic tree) and Rho (weight of the independent 
component of the FunDi mixture model) values estimated by FunDi.  
Genes in our dataset were also separated into two-member and three or more-member 
gene families. Gene families with more than two paralogs are more difficult to accurately 
characterize and feature more complex, and overlapping, comparisons.   
 For the scatter plots, the Pearson correlation test was used to measure the strength of the 
relationship between two variables. For the box plots, two-sided Wilcoxon-Mann-Whitney U-
tests were used to evaluate the existence of significant differences between two independent 
groups. For both tests, the obtained P-values measured the significance of the tested 
relationships. In addition, Bonferroni correction (also known as the Bonferroni type adjustment 
(Bonferroni, 1936; Dunn, 1959; Armstrong, 2014)) was made on the P-values in order to reduce 
the chance for a false positive error; rejecting the null hypothesis when I should not. 
In order to better visualize the correlation of numerical data whose ranges differ 
significantly in magnitude, the Rho values were re-scaled using the following function:  
                             Logit = Ln [Rho / (1-Rho)]                                                       (1) 






All reported P-values were corrected for multiple comparisons using the Bonferroni method in 
order to reduce false-positive errors in the analysis.  
 
3.1 Branch Length Results from Phylogenetic Trees 
The relationship between internal branch length values and the FunDi functional divergence 
score, Rho, for each gene family are shown in figure 3 for the two-member only (A&B) gene 
family groups, both before (A) and after (B) FunDi optimization. Similarly, the results for three 
or more-member (3+) gene families are also shown (C&D). For the two-member gene families 
there were 78, 125, and 1145 sets of alignments and phylogenetic trees for the AD, AR, and ND 
categories respectively. For the three or more-member gene families there were 217, 210, and 
3172 alignments and phylogenetic trees for the AD, AR, and ND categories respectively. 
 For the group of two-member gene families, the Pearson correlation coefficient in the ND 
and AR groups of genes, both before and after internal branch length optimization with FunDi, 
had relatively weak positive (before optimization: ND: r = 0.613, P = 0.0002 and AR: r = 0.660, 
P = 0.0002; Fig. 3A; after optimization: ND: r = 0.126, P = 0.0002, AR: r = 0.147; P = 0.2060; 
Fig. 3B) correlation between the functional divergence weight parameter, Rho, and the internal 
branch length. However, this relationship was not statistically significance in the ND category 
after optimization of the internal branch length. The AD subcategory did not have a statistically 
significant correlation between Rho and the internal branch length before or after FunDi 
optimization (before optimization: AD: r = 0.187, P = 0.2080; Fig. 3A; after optimization: AD: r 
= 0.001, P = 1; Fig. 3B).  
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For the 3+ gene family groups, the Pearson correlation coefficient had a strong positive 
measure between in the AR subcategory, and a weak positive correlation in the ND category and 
AD subcategory. There was statistical significance for all three subcategories before optimization 
with FunDi (before optimization: ND: r = 0.613, P = 0.0002, AR: r = 0.726, P = 0.0002, and AD: 
r = 0.650,  P = 0.0002; Fig. 3C), and after FunDi analysis all three gene categories had relatively 
weak positive relationships, although it was not significant for the AD group (after optimization: 
ND: r = 0.067, P = 0.0002, AR: r = 0.188, P = 0.0120, and AD: r = 0.036, P = 1; Fig. 3D).  
The distribution of internal branch length values, before and after FunDi optimization, for 
each disease-gene category are shown in figure 4 for the two-member only (A) gene family 
groups. Similarly, the results for three or more-member (3+) gene families are also shown (B). 
We tested for differences in the distribution of branch length between the AD and AR gene 
categories with those of ND genes as described in the methods.  
For the two-member gene family group (A), a significant difference was only seen 
between the ND and AR gene categories before FunDi optimization (before optimization: ND vs. 
AR: P = 0.0256, and ND vs. AD: P = 1; after optimization: ND vs. AR: P = 0.2110, and ND vs. 
AD: P = 0.7706; Fig. 4A).  
For the 3+ group of gene families (B), no significant difference was found between any 
of the gene categories before FunDi optimization, but a significant difference was seen between 
the distribution of internal branch lengths when comparing the ND gene category and the AR 
category after branch length optimization with FunDi (before optimization: ND vs. AR: P = 
0.2482, and ND vs. AD: P = 1; after optimization: ND vs. AR: P = 0.0032, and ND vs. AD: P = 
0.4552; Fig. 4B).  
We also analyzed the distribution of the difference between pre- and post-FunDi 
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optimization of the internal branch length (Fig. 5), for both the two-member (A) and 3+ member 
(B) gene families. Here the difference in branch lengths is a measure of improvement in model 
fit when FunDi is used versus a standard evolutionary model. No statistically significant 
difference was found for either comparison (ND vs. AR: P = 0.0552, and ND vs. AD: P = 1; Fig. 
5A). For the 3+ gene family group (B), no significant result was found for any comparison 
(before and after optimization difference: ND vs. AR: P = 1, and ND vs. AD: P = 1; Fig. 5B).  
 
3.2 Rho Value - Functional Divergence Results 
Boxplots of the Rho values obtained for each group are shown in figure 6. For our analysis of the 
functional divergence score, Rho, no significant differences were seen between either the AD or 
AR category when compared to the ND category in either the two-member (ND vs. AD: P = 1, 
and ND vs. AR: P = 0.4422; Fig. 6A) or 3+ member (ND vs. AD: P = 0.8436, and ND vs. AR: P 
= 0.4712; Fig. 6B) groups.  
 While Rho is the most direct measure of functional divergence output by FunDi, we also 
compared the fraction of sites considered to be functionally divergent when using different cut-
offs for the site-wise posterior probability of functional divergence output by FunDi. Boxplots of 
the fraction of functionally divergent sites for each gene category are shown in figure 7. For our 
analysis of the fractions of the functionally divergent sites, no significant differences between 
either the AD or AR categories when compared to the ND genes were seen for any category in 
the two-member group (fraction 0.5: ND vs. AD: P =1, and ND vs. AR: P = 0.1814; fraction 
0.75: ND vs. AD: P = 1, and ND vs. AR: P = 0.3522; fraction 0.9: ND vs. AD: P = 1, and ND vs. 
AR: P = 0.9050; fraction 0.95: ND vs. AD: P = 1, and ND vs. AR: P = 0.8908; Fig. 7A). 
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For the 3+ member group, a statistically significant difference was only seen when 
comparing AR genes to ND genes when using the most conservative (0.9 and 0.95) cutoff for 
defining functionally divergent sites in the multiple sequence alignment comparing (fraction 0.5: 
ND vs. AD: P = 0.9808, and ND vs. AR: P = 0.7532; fraction 0.75: ND vs. AD: P = 1, and ND 
vs. AR: P = 0.1452; fraction 0.9: ND vs. AD: P = 1, and ND vs. AR: P = 0.0222; fraction 0.95: 
ND vs. AD: P = 1, and ND vs. AR: P = 0.0062; Fig. 7B). The results for figure 7 are illustrated 
in table 1. 
 
Discussion  
4.1 Observation and Predictions 
Previous studies have shown that genes that cause Mendelian disease are overrepresented among 
genes that have been duplicated in the course of evolution (Chen et al., 2013; Chen et al., 2014; 
Singh et al., 2012; Singh et al., 2014). Our approach focused on analyzing the relationship 
between functional divergence and the propensity of gene families to be involved in Mendelian 
disease using three measures of functional divergence (Rho, the difference between pre- and 
post-optimized internal branch length, and the fraction of functionally divergent sites in the 
multiple sequence alignment) as well as a measure of the evolutionary distance between paralogs 
(internal branch length), which functions as a more indirect, and nonspecific, measure of 
functional divergence.  
As a prediction, we expected to see some significant difference between gene families 
that cause Mendelian disease (MD) or specific categories of disease (AD and AR) when 
compared to non-disease causing gene families (ND). The reasoning behind this prediction was 
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the assumption that duplicated genes that cause Mendelian disease evolved differently than non-
disease genes. As previously stated, evolutionary pressures such as mutation and selection act 
independently on duplicated genes, releasing them from the constraints of their original function 
(Qian & Zhang, 2014; Chen et al., 2013; Chen et al., 2014; Innan & Kondrasov, 2010). Previous 
studies have shown that disease-associated genes, when compared to all other genes, were more 
conserved at the protein level (López‐Bigas & Ouzounis, 2004; Huang et al., 2004; Smith & 
Eyre-Walker, 2003; Tu et al., 2006). Therefore, some significance between the two categories 
must be present at some level. 
 In addition to the previous prediction, when comparing the two Mendelian disease 
subgroups, we hypothesized that gene families that cause autosomal dominant diseases 
specifically (AD) may show more functional divergence than those that cause autosomal 
recessive diseases (AR). This would indicate that evolutionary forces acted strongly on gene 
families in that category, resulting in a greater degree of functional diversity between paralogs in 
these genes compared to either AD or ND genes (Singh et al., 2014). In addition, this may 
provide evidence that may support or reject the compensation hypothesis (Chen et al., 2013; 
Chen et al., 2014). The rationale behind this prediction is that in dominant disorders we do not 
expect functional compensation, as only one copy of the disease-associated allele is required to 
cause disease, whereas in the recessive case, both alleles need to be affected to cause disease 
(Chial, 2008). In addition, due to the fact that a single copy of the normal gene cannot 
compensate in a dominant disease, we do not expect a paralog to be able to compensate either. 
Therefore, there won’t be any selective pressures to maintain a compensatory copy, allowing for 
greater functional divergence. 
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4.2 Results of the Analyzed Datasets - Proposed Explanations 
Despite my predictions, my results mainly showed no significant differences in the most direct 
signature of functional divergence, the Rho weight parameter, between disease-causing and non-
disease causing gene categories. The results were plotted using the FunDi output values, and 
included the internal branch lengths, Rho value, and fractions of functionally divergent sites.  
For my prediction, I expected Rho values and pre-optimized internal branch length values 
to correlate with one another when comparing the results before and after FunDi optimization, as 
I assumed that genes that are more divergent tend to have longer branch lengths (Gu, 2001). My 
results showed that before optimizing with FunDi, there was relatively strong correlation 
between the categories, except the AD category in the two-member gene family group (Fig. 3). 
Since FunDi accounts for functional divergence in its model, it tends to result in a shortening of 
the branch lengths, which would break the correlation between Rho values and internal branch 
length values, as Rho stays constant between the two graphs. Therefore, my observation in 
general is exactly what I expect to see. 
When I tested for differences in the distribution of internal branch lengths between the 
AD versus ND category and AR versus ND category, statistical significance was seen only 
between AR and ND categories but only when looking at the two-member gene family pre-
FunDi optimization and three or more-member gene family post-FunDi optimization (Fig. 4). As 
expected, the results showed shortening of the internal branch lengths after optimizing the values 
with FunDi, which showed that FunDis’ optimization tended to results in shorter internal branch 
lengths than those of the starting pre-optimization tree. The statistically significant difference 
observed between AR and ND categories in the two-member gene family group was no longer 
seen after FunDi optimization, as was expected, but it was interesting to see that in the three or 
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more-member gene family group a statistical significance was gained after FunDi optimization. 
This could represent a false result as FunDi was not specifically designed to handle groups such 
as the three or more-member gene families as well as the two-member families. 
In order to see how effective FunDi was in optimizing and shortening the internal branch 
length values for the two groups, I calculated the difference (Δ-delta) between pre- and post-
optimized internal branch lengths (Fig. 5). With that, I wanted to see if FunDi’s optimization has 
significantly shortened the internal branch lengths. Before the correction, the results showed that 
there was a statistical significance when comparing the AR and ND categories in the two-
member gene family group, but after the correction it was no longer significant, although it was 
relatively close to the threshold. The three or more-member gene family group did not show any 
statistically significant results in any of the analyzed categories. One possible explanation for this 
observed difference when comparing between the two-member gene family group versus the 
three or more-member gene family group is the difference in the relationships between the two. 
The two-member gene family group has relatively simple relationships, while the three or more-
member group has more complex relationships where there are potentially multiple subgroups 
within the tree undergoing functional divergence. FunDi is designed to explicitly model 
functional divergence that occurs along a single internal branch. While it is probably a better 
model than the standard evolutionary model, it still has shortcomings in some of these situations. 
 For my prediction, I expected to see significant differences in Rho values between the 
categories for both groups. My results did not see eye to eye with my logic and showed no 
significance in any category, for any of the analyzed groups (Fig. 6). As mentioned, Rho is the 
optimized weight of the independent component of the FunDi mixture model, which is a measure 
of the functional divergence between paralogs. I did not detect any statistically significant 
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difference between either category, the disease-associated genes and non-disease causing genes. 
Either functional divergence does not explain the difference between disease-causing and non-
disease causing paralogs, which also calls into question the functional compensation hypothesis, 
or my method did not detect the right signal of functional divergence. An additional possibility 
lies in the nature of the training set itself. Because the underlying genetic mutation causing many 
Mendelian diseases is still not known, the non-disease category does contain a significant 
number of false negative classifications. However, given the size of the datasets involved, and 
the size of the non-disease category compared to the disease category, I would expect this impact 
to be moderate.  
As mentioned, Rho is the most direct measure of functional divergence output by FunDi, 
but also considered to be a broad measure of functional divergence, that reflects the total signal 
of functional divergence within the protein alignment file. This includes sites with both weak and 
strong signals of divergence. Strongly divergent sites are expected to be the most functionally 
important when looking at the difference in functions between paralogs. I predicted that a 
refinement of the functional divergent sites will provide a different answer. As mentioned, to 
determine whether the site is functionally divergent or not is dependent on a set cut-off threshold 
(standard threshold is 0.5), which is based on the posterior probability of functional divergence 
for individual sites. I set different thresholds (0.75, 0.9, and 0.95) and tested the fraction of 
functionally divergent sites in the alignment files for each of these cut-offs. The cut-offs created 
restrictions which allowed us to look progressively at only the fraction of sites with the strongest 
signals of functional divergence (Fig. 7). Results from the analyzed fractions did not shed new 
light on the stated prediction of Rho.  
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4.3 Conclusions and Further Research 
Measures of functional divergence did not explain whether they are correlated with the 
propensity of duplicated genes to be involved in Mendelian Disease. Rho value, that represents 
the functional divergence weight, was not the factor that explained the overrepresentation of 
Mendelian Disease genes among the duplicated genes in my dataset. 
Further research is required in order to provide an explanation for the overrepresentation 
of the Mendelian Disease gene among the duplicated genes, as Rho failed to explain the 
observation. One approach will be to test alignment files of each dataset for # of individual 
amino acid positions. This will allow us to focus on the genome positions that actually differ 
between genes, instead of looking at the whole genome. Another approach will be calculation of 
the maximum likelihood values for each of the dataset's branch lengths in the phylogenetic tree. 
This will provide an additional parameter that can be a factor that explains the observation. Third 
approach will be to try to look at other measures of functional divergence, like sequence entropy 
(Schmitt & Herzel, 1997), which is a mathematical approach that measures diversity. 
In addition, it is important to note that only one database was analyzed, and it had its own 
specific categorization. Expanding the research to other databases might provide different 
results. Furthermore, there is still a lot we don’t know about the disease genes and there is a 
possibility that some disease genes weren’t categorized as such and are still considered as non-
disease ones. This might give us a false-positive error which will affect the results. Aggregation 
of data from multiple databases and creation of one big database, with defined categorization 
might also provide more information on the analyzed genes and give better results. Lastly, 
optimizing FunDi algorithm in order to better handle the more complex relationships between 
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Figure 1. Steps taken to create the datasheet of datasets from the original Chen et al., (2013) 















Figure 2. Visualization of the algorithm: (1.) The algorithm starts from a terminal node that 
contains the protein ID. (2.) Traversing through the tree to an inner node. (3.) Traversing. (4.) 
Traversing until finding a node that contains a paralog that is associated with the protein ID from 









Figure 3. Scatterplots showing the correlation between Rho value (FD Weight) versus Branch 
Length values of each gene families’ phylogenetic tree, before using FunDi and after for all gene 
categories: AD- Autosomal Dominant, AR- Autosomal Recessive, and ND- Non-Disease genes. 
(A) Two-member gene family scatterplot results before using FunDi. (B) Two-member gene 
family scatterplot results after using FunDi. (C) Three or more-member gene family scatterplot 













Figure 4. Boxplots showing the comparison between Branch Length values of each gene 
families’ phylogenetic tree, before using FunDi and after for all gene categories: AD- Autosomal 
Dominant, AR- Autosomal Recessive, and ND- Non-Disease genes. (A) Two-member gene 
family scatterplot results before and after using FunDi. (B) Three or more-member gene family 
scatterplot results before and after using FunDi. P-values obtained from a two-sided Wilcoxon-







Figure 5. Boxplots showing the difference between the values of the branch lengths (pre vs. 
post) before using FunDi and after for all gene categories: AD- Autosomal Dominant, AR- 
Autosomal Recessive, and ND- Non-Disease genes. (A) Two-member gene family boxplot 








Figure 6. Boxplots showing the comparison of Rho (FD Weight) values for all gene categories: 
AD- Autosomal Dominant, AR- Autosomal Recessive, and ND- Non-Disease genes. (A) Two-







Figure 7. Boxplots showing the comparison between fractions of Rho (FD Weight) values for all 
gene categories: AD- Autosomal Dominant, AR- Autosomal Recessive, and ND- Non-Disease 
genes. (A) Two-member gene family boxplot results. (B) Three or more-member gene family 
boxplot results. P-values obtained from a two-sided Wilcoxon-Mann-Whitney U-test for the 






Table 1. Visualization of fractions of Rho value comparison between the analyzed categories 
after Bonferroni correction. 
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